Found: 3
Select item for more details and to access through your institution.
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The lack of head-to-head randomised trials and the consequences for patients and national health service: The case of non-small cell lung cancer.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 519, doi. 10.1007/s00228-024-03628-2
- By:
- Publication type:
- Article
Clinical Outcomes of Patients with Advanced Cancer and Pre‐Existing Autoimmune Diseases Treated with Anti‐Programmed Death‐1 Immunotherapy: A Real‐World Transverse Study.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e327, doi. 10.1634/theoncologist.2018-0618
- By:
- Publication type:
- Article